Metabolix (MBLX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation and amortization	458K
Charge for 401(k) company common stock match	259K
Stock-based compensation	1.16M
Receivables (billed and unbilled)
Due from related party	145K
Prepaid expenses and other assets	1.41M
Accounts payable	122K
Accrued expenses	-1.05M
Deferred rent and other long-term liabilities
Deferred revenue	-277K
Net cash used in operating activities	-12.26M
Purchase of property and equipment	-721K
Change in restricted cash	187K
Purchase of short-term investments
Proceeds from the sale and maturity of short-term investments
Net cash provided by (used in) investing activities	9.78M
Proceeds from options exercised
Proceeds from public stock offering, net of offering costs of $2,336
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of period	12.27M
Cash and cash equivalents at end of period	9.78M

Entities mentioned with MBLX

View All Entities